Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita
Francesca Fioredda(Istituto Giannina Gaslini), Carlo Dufour(Istituto Giannina Gaslini), Elisabeth T Korthof(Europdonor Foundation), Jean‐Hugues Dalle(Inserm), Reuven Or(Hadassah Academic College), Cora Knol(European Society for Blood and Marrow Transplantation), Е. В. Скоробогатова(Russian Children's Clinical Hospital), Owen Smith(Trinity College Dublin), Antonio M. Risitano(European Society for Blood and Marrow Transplantation), Marco Zecca(Policlinico San Matteo Fondazione), Maura Faraci(Istituto Giannina Gaslini), J de la Fuente(St Mary's Hospital), Ayami Yoshimi(University of Freiburg), Tracey O’Brien(Sydney Children's Hospital), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Julián Sevilla(University of Southern Denmark), Jakub Tolar(University of Minnesota System), Paul Veys(Great Ormond Street Hospital), Michael Maschan(Russian Children's Clinical Hospital), Franca Fagioli(Ospedale Regina Margherita), Dorine Bresters(Willem-Alexander Kinderziekenhuis), Luca Arcuri(Istituto Giannina Gaslini), Régis Peffault de Latour(Hôpital Saint-Louis), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Anja van Biezen(European Society for Blood and Marrow Transplantation), Ardeshir Ghavamzadeh(Tehran University of Medical Sciences), Miguel Ángel Díaz(Hospital Infantil Universitario Niño Jesús), Petr Sedláček(University Hospital in Motol), Brune Mats(Sahlgrenska University Hospital), Simona Iacobelli(Universität Hamburg), Alain Fisher(Délégation Paris 5), Maria Teresa Van Lint(Ospedale Policlinico San Martino), Maurizio Miano(Istituto Giannina Gaslini)
Cited by 81
Related Papers
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k